Morgan Stanley downgrades e.l.f. Beauty stock rating on market share losses

Morgan Stanley downgraded e.l.f. Beauty to Equalweight from Overweight and cut its price target to $67 from $80, citing worsening market share losses in core U.S. cosmetics and a likely slowdown after price increases roll off. The stock has fallen 15% year-to-date and 48% over the past six months, though recent Q3 fiscal 2026 results beat expectations with EPS of $1.24 versus $0.70 consensus and revenue of $489.5 million versus $455.82 million. Offset to the downgrade, rhode expansion and Naturium growth remain positive, but near-term sentiment is pressured by core share weakness.

Analysis

The key setup is not that ELF is simply losing share; it is that the market is likely underestimating the lag between a fundamental inflection and visible revisions. If core U.S. cosmetics rolls over after the pricing cycle, the selloff could be front-loaded because the base business has historically acted as the valuation anchor, while the “new platform” narrative only cushions sentiment until investors see the second derivative flatten. That means the next catalyst is less about quarterly beats and more about whether sell-through data and channel checks show a sustained unit share leak into fall.

The second-order effect is that rhode’s success can become a mixed blessing. Near term, it supports top-line optics and keeps bulls engaged; over a 12–18 month horizon, though, the market may start treating it as a slower-to-monetize, lower-multiple growth asset if it simply offsets deterioration elsewhere rather than reaccelerating the whole platform. In that scenario, the multiple compresses even if revenue remains acceptable, because the story shifts from “category winner” to “portfolio patchwork.”

On the competitive side, any softness in ELF’s core opens room for legacy prestige brands and private-label players to reclaim shelf productivity without needing outright category growth. If beauty demand is stable, the loser is likely ELF’s share, not the category; that matters because lost unit velocity usually leads retailers to tighten resets and promo support with a multi-quarter delay. The market is probably also underpricing how quickly margin support can erode if the company must defend share with heavier promotional intensity just as investors are re-rating the stock on slower growth.

The contrarian angle is that the downgrade may be arriving closer to the actual inflection than the tape suggests. If consensus has been anchored to upbeat recent earnings, the risk is that the next two data points are less about earnings surprises and more about guidance credibility; once that shifts, the stock can gap down quickly even without a large estimate cut. The right framing is not “is ELF cheap?” but “is the market paying too much for a business whose growth composition is getting less defensible?”

Key Decisions for Investors

• Short ELF on strength into any post-downgrade bounce; 1–3 month horizon, with downside to prior support if fall sell-through data confirms core share loss. Risk/reward is attractive because valuation support can disappear quickly if the market starts pricing a declining core franchise.
• Use put spreads on ELF 2–4 months out rather than outright shorts; this captures the likely catalyst window into fall while limiting squeeze risk if rhode-Europe headlines temporarily support sentiment.
• Pair trade: short ELF vs long a diversified prestige/beauty beneficiary with stronger retailer leverage, such as ULTA or EL, over the next 3–6 months. The thesis is that share leakage hurts ELF more than it helps the category leaders, and the relative trade reduces beta to the broader consumer tape.
• For event-driven traders, wait for the next channel-check / quarterly guidance update before adding size; the market is likely to penalize confirmation of unit-share erosion more than the existing sell-side downgrade itself.
• Tactically, avoid chasing UBS-style upside targets until there is evidence that core cosmetics stabilizes for at least one full sell-through cycle; otherwise the risk/reward skews toward multiple compression over fundamental catch-up.